Translational Approaches to Non-Motor Symptoms of Neurodegenerative Diseases, Volume 173 in the International Review on Neurobiology series, highlights new advances in the field Read more. articles, subject to any requirements of third-party copyright owners Correction: Olfactory swab sampling optimization for-synuclein aggregate detection inpatients with Parkinson's disease. Impact Factor: 9.883 Citescore: 12 SCIMAGO SJR: 1.849 SCIMAGO H-index: 45 Research Ranking (Neuroscience) 223 Research Ranking (Medicine) 1862 Number of Best scientists*: 12 Documents by best scientists*: 16 Journal Information ISSN: 2047-9158 Publisher: Editors-in-Chief: See all (170) Specialty Chief Editor. Citation Impact 9.883 -2-year Impact Factor(2021) 9.260 -5-year Impact Factor(2021) 1.762 -Source Normalized Impactper Paper (SNIP) 1.849 - SCImago Journal Rank (SJR), Speed 8 days to first decision for all manuscripts (Median) 15 days to first decision for reviewed manuscripts only (Median), Usage 711,033 Downloads (2022) 573Altmetric mentions (2021). The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms. appropriate credit is given and any changes specified. Gut dysmotility in rodents and its central origin10. Mahmoud Iravani has a long standing research interest in neurodegeneration mechanisms in Parkinsons Disease and L-Dopa induced dyskinesia with Peter Jenner at Neurodegenerative Disease Research Centre at King's College London. By using this website, you agree to our The decision to accept an article needs to be unanimous amongst all reviewers and the handling Associate Editor. She is also Head of Department of Pharmacology & Therapeutics, responsible for delivery of pharmacology education to undergraduate and masters students. Psychosis4. Inaugurated in 2011 under the editorship and leadership of Dr. Shengdi Chen, our mission is to promote and foster rapid conversion of basic science research to clinical applications by offering a high-visibility forum for groundbreaking translational research in neurodegenerative diseases and to ultimately benefit not only patients but also societies. The latest SCImago Journal Rank (SJR) of Translational Neurodegeneration is 1.849. The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values. Terms and Conditions, scientist or scholar. Our goal is to provide a comprehensive forum through which quality research can be disseminated to a wide audience. Careers, Unable to load your collection due to an error. FOIA
Translational Neuroscience - De Gruyter Time taken from draft submission to final publication. The h-index is a way of measuring the productivity and citation impact of the publications. 2023 Frontiers Media S.A. All rights reserved, Neuroenergetics, Nutrition and Brain Health. ISSN: 2081-3856. It is computed in the year 2022. A second project, which is still ongoing, has involved imaging of the structural changes in the primate brains following MPTP treatment, using MRI at the Institute of Psychiatry. Jianqing Ding and Yuyan Tan, managing editors of Translational Neurodegeneration, to the leaders, colleagues, team members of Rui Jin Hospital. The Associate Editor is aided in this by the Frontiers Collaborative Review Forum software and interface, which suggests the most relevant Review Editors based on a match between their expertise and the topic of the manuscript. For topics on particular articles, maintain the dialogue through the usual channels with your editor. quality of the research articles that are published: Only leading experts and established members of the research community are appointed to the Frontiers Editorial Boards. Translational Neurodegeneration is published by BioMed Central Ltd.. Name
It means 45 articles of this journal have more than 45 number of citations. According to a report released by the United Nations, 1 in 11 world population was over 65 in 2019 and by 2050 the ratio will be almost doubled to 1 in 6. A scale of 5 feelings conveyed using images that range from awful to great. Find out more about the research published in Translational Neurodegeneration by reading our authors' Behind the Paperposts. Volumes and issues. Translational Neurodegeneration 11, Article number: 4 ( 2022 ) Cite this article 9717 Accesses 32 Citations 73 Altmetric Metrics Abstract Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to arise as the disease progresses. Click to reveal
Translational Neurodegeneration - SCI Journal Should it become clear that a particular reviewer has a conflict of interest or is unable to perform the peer-review timely and adequately, he or she shall be replaced with an alternative reviewer by the Associate Editor or the Chief Editor, who will be alerted and has full control to intervene into the peer-review at any time. Impact Factor 10.7 (top 1%) extended IF 49 (top 8%) H-Index 315 authors 347 papers 8.8K citations 1.6K citing journals 9.8K citing authors Selected Period: - Re-Draw The graph shows the changes in the impact factor of Translational Neurodegeneration and its the corresponding percentile for the sake of comparison with the entire literature. The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. of scholarly journals that accounts for both the number of citations These new technologies along with multidisciplinary approaches will undoubtedly open new frontiers in discovering early diagnosis methods and developing treatment for these diseases. It is published by BioMed Central Ltd.. Your IP: such citations come from. We have identified the following critical areas for translational neurodegenerative diseases research: (1) To identify and validate biomarkers for early or pre-clinical diagnosis and for use as endpoints of clinical progression through strategies such as proteomics, genomics, metabolomics and functional imaging techniques in combination of artificial intelligence; (2) To promote clinical development through the latest innovative technologies such as neuroimaging strategies, stem cell technology, exosome technology and nanotechnology; and (3) To accelerate drug development and marketing through big cohort clinical trials; and more importantly, these clinical efforts will generate a multitude of new ideas and contacts that can be fed back for more focused/targeted research. Evolution of the number of total citation per document and external citation per document (i.e. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. materials is always subject to any copyright notices displayed. The section aims at publishing important basic research, as well as translational and clinical findings in the field of neurodegeneration. Notably, the number of cases of dementia in the developed world is projected to rise from 13.5 million in 2000 to 21.2 million in 2025, and to 36.7 million in 2050. None have a financial incentive to accept articles, i.e. Translational Neurodegeneration | Read 398 articles with impact on ResearchGate, the professional network for scientists. the contents by NLM or the National Institutes of Health. If the same upward trend persists, (Australia) are fully compatible with publishing in Frontiers. Sorry, this title is not available for purchase in your country/region. Universities and research institutions in United Kingdom
Springer Nature. Stress/fatigue/ cognitive decline Sleep / autonomic failure, A general clinical overview of the non-motor symptoms psychiatric symptoms3. We and our partners share information on your use of this website to help improve your experience. Copyright 2023 Cactus Communications. It is based on the idea that 'all citations are not created equal'. December 2020, issue 1; Volume 8 December 2019. readership towards public understanding. and subject to the original publication being fully cited. This journal's impact score, h-index, and SJR are 8.86, 45, and 1.849, respectively. At the University of Herfordshire his focus will be primarily on Parkinsons disease neuropathology as well as novel treatments for L-dopa induced dyskinesia. Long term adaptive changes to autonomically innervated smooth muscle contractility in a primate model of PD. MITPress. However, this honorarium is based on the total number of submitted articles during a calendar year, and not the number of accepted articles. While we are facing historical challenges of COVID-19, we are also facing significant challenges of a fast-growing aging society. Sleep disorders May 31, 2023 feature Editors' notes Sleep deprivation is a risk factor for Alzheimer's, say scientists who turned to animal models to find out why by Delthia Ricks , Medical. Neurodegener.') During the past ten years, we have been witnessing splendid progresses in TN. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and . On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. The International Standard Serial Number (ISSN) of Translational Neurodegeneration is/are as follows: 20479158. A key focus is to find drugs to combat the neurodegeneration underpinning Parkinson's. As well as identifying novel targets for achieving this, such as mGlu4 receptors, we use targeted repurposing strategies to identify existing drugs that boost protective growth factor levels and explore novel delivery mechanisms for the growth factors . Here are some critical parameters that are considered while calculating the acceptance rate: The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website. Cellular and Molecular Neuroscience (Q1); Cognitive Neuroscience (Q1); Neurology (clinical) (Q1). The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. According to SCImago Journal Rank (SJR), this journal is ranked 1.849. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher. It is evaluated in the year 2022. Long-term hyperglycemia aggravates -synuclein aggregation and dopaminergic neuronal loss in aParkinson's disease mouse model. The site is secure. Frontiers has a number of procedures in place to support and ensure the 2022 marks the 10th anniversary of Translational Neurodegeneration.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal's impact. * Required, Email(will not be published)
in other publications. The Associate Editor assesses the reviews and activates the Interactive Review informing the authors of the extent of revisions that are required to address the reviewers comments, and starting the Interactive Discussion Forum where authors and also the reviewers get full access to all review reports. December 2021, issue 1; Volume 9 December 2020. Translational Neurodegeneration published with a Continuous publication frequency. The Associate Editor can also weigh in on the discussion and is asked to mediate the process to ensure a constructive revision stage. Translational Neuroscience. Cookies policy. Special Issue Proposals Through cooperation we will be able to learn cutting-edge methods/technologies and to adjust plans accordingly and timely. You can email the site owner to let them know you were blocked. At the beginning of 2022, we are celebrating the 10th birthday of our journal, Translational Neurodegeneration (TN).
Frontiers in Neuroscience | Neurodegeneration The coverage history of this journal is as follows: 2012-2021. This website is using a security service to protect itself from online attacks. Submitting authors can choose a preferred Associate Editor to handle their manuscript, because they can judge well who would be an appropriate expert in editing their manuscript. The publication country of this journal is United Kingdom. We are with you every step of the way as you achieve your dreams - publication, everything that precedes it, and everything that comes after. Cloudflare Ray ID: 7d1bf26b5e8b6919 SCImago Journal Rank is an indicator, which measures the scientific influence of journals. She has received Teaching Excellence Awards from Kings College London and the British Pharmacology Society in recognition of her innovative education. The publishing house of this journal is located in the United Kingdom. The ability to copy, download, forward or otherwise distribute any owners. Immediately download your ebook while waiting for your print delivery.
Translational Neurodegeneration - Scimago Journal & Country Rank Associate Editor. The 2021-2022 Factor de Impact of Translational Neurodegeneration is 8.014, which is just updated in 2022. We also thank Springer Nature, our publisher, for their help in making this fast-growing journal possible in the past ten years. ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
We are always looking for inspiration, feedback, and collaborators. For PD, the second most common neurodegenerative disease after AD, we are facing these daunting challenges as well. All manuscripts must be submitted directly to the section Undergraduates, graduates, academics, and researchers in the field of Non-Motor Symptoms of Neurodegenerative Diseases, A general clinical overview of the non-motor symptoms 1.
National Library of Medicine While we received only 31 submissions in 2012, in 2021 by Nov. 22nd the number of submissions has rocketed to 274. SCImago Journal Rank (SJR indicator) is a measure of scientific influence The challenges in 2021 have continued to occur as we unceasingly fight against the pandemic. Neurodegener.. The International Organization for Standardization 4 (ISO 4) abbreviation of Translational Neurodegeneration is Transl. Frontiers is well aware of the potential impact of published research Neurodegener.. Translational Neurodegeneration is a journal published by BioMed Central Ltd..
Translational Neurodegeneration: Impact Factor, Ranking, H-Index, ISSN The best quartile of Translational Neurodegeneration is Q1. Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and glaucoma. Inclusion in an NLM database does not imply endorsement of, or agreement with, As the global population ages, the prevalence of neurodegenerative disorders, including Alzheimers disease (AD) and Parkinsons disease (PD), is fast increasing. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. The scope of Translational Neurodegeneration is as follows: For detailed scope of Translational Neurodegeneration, check the official website of this journal. Enter journal title, issn or abbr in this box to search. Authors: Ping Yuan, Yong Bi, Yu Luo, Quan Tao, Sugang Gong, Yi Wang, Lize Xiong, Xiaohuan Xia and Jialin C. Zheng, Authors: Jung Hwan Shin, Heejung Kim, Yu Kyeong Kim, Eun Jin Yoon, Hyunwoo Nam, Beomseok Jeon and Jee-Young Lee, Authors: Katherine E. Olson, Mai M. Abdelmoaty, Krista L. Namminga, Yaman Lu, Helen Obaro, Pamela Santamaria, R. Lee Mosley and Howard E. Gendelman, Authors: Zhihai Huang, J. Dedrick Jordan and Quanguang Zhang, Authors: Kelsie M. LaBarbera, Yvette I. Sheline, Nicholas J. Izzo, Carla M. Yuede, Lora Waybright, Raymond Yurko, Hannah M. Edwards, Woodrow D. Gardiner, Kaj Blennow, Henrik Zetterberg, Anne Brjesson-Hanson, Roger Morgan, Charles S. Davis, Robert J. Guttendorf, Lon S. Schneider, Steven DeKosky, Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China Li Cao, Xiaojun Huang, Ning Wang, Zhiying Wu, Cheng Zhang, Weihong Gu, Shuyan Cong, Jianhua Ma, Ling Wei, Yanchun Deng, Qi Fang, Qi Niu, Jin Wang, Zhaoxia Wang, You Yin, Jinyong Tian, Shufen Tian, Hongyan Bi, Hong Jiang, Xiaorong Liu, Yang L, Meizhen Sun, Jianjun Wu, Erhe Xu, Tao Chen, Tao Chen, Xu Chen, Wei Li, Shujian Li, Qinghua Li, Xiaonan Song, Ying Tang, Ping Yang, Yun Yang, Min Zhang, Xiong Zhang, Yuhu Zhang, Ruxu Zhang, Yi Ouyang, Jintai Yu, Quanzhong Hu, Qing Ke, Yuanrong Yao, Zhe Zhao, Xiuhe Zhao, Guohua Zhao, Furu Liang, Nan Cheng, Jianhong Han, Rong Peng, Shengdi Chen & Beisha Tang Review | 16February 2021, COVID-19 and Alzheimers disease: how one crisis worsens the other Xiaohuan Xia, Yi Wang & Jialin Zheng Review | 30 April 2021, The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population Dongchao Shen, Xunzhe Yang, Yanying Wang, Di He, Xiaohan Sun, Zhengyi Cai, Jinyue Li, Mingsheng Liu & Liying Cui Research | 09 August 2021, Cross-talks among GBA mutations, glucocerebrosidase, and -synuclein in GBA-associated Parkinsons disease and their targeted therapeutic approaches: a comprehensive review Tapan Behl, Gagandeep Kaur, Ovidiu Fratila, Camelia Buhas, Claudia Teodora Judea-Pusta, Nicoleta Negrut, Cristiana Bustea & Simona Bungau Review | 15 January 2021, Immunotherapy for Alzheimers disease: targeting -amyloid and beyond Chenghuan Song, Jiyun Shi, Pingao Zhang, Yongfang Zhang, Jianrong Xu, Lanxue Zhao, Rui Zhang, Hao Wang & Hongzhuan Chen Review | 18 March 2022, Thematic seriesRecent progresses on early diagnosis of Parkinsons disease and related disorders Edited by Anthony E. Lang, Thematic seriesClearance of neurotoxic proteins in proteinopathies: from clearance pathways to therapeutic targets Edited by Shengdi Chen, Thematic seriesPD progresses in recent 10 years: from hypothesis to therapeutic targets Edited by Shengdi Chen, Thematic seriesAD progresses in recent 10 years: from hypothesis to therapeutic targets Edited by Weihong Song, Thematic seriesMicroRNAsand neurodegenerative diseases Edited by Zixu Mao, Thematic seriesMitochondria dysfunctions and neurodegenerative diseases Edited by Xiongwei Zhu, Thematic seriesUpdate on Amyotrophic lateral sclerosis: from genetic and mitochondria perspective Edited by Shengdi Chen and Jialin ZhengThematic seriesStem cell-based therapy for Alzheimers disease: the current situation and future prospectsThematic seriesPharmacological treatment for early and advanced stages of Parkinsons disease: current and future strategies Edited by Shengdi Chen and Jialin Zheng, Cross journal collectionReviewer acknowledgements 2013. The publication protocol for Translational Neurodegeneration is to publish new original papers that have been rigorously reviewed by competent scientific experts. The Associate Editor can then personally choose and invite the most appropriate reviewers to handle the peer-review of the manuscript, including Review Editors from the board or external reviewers. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page. SCImago Journal Rank (SJR) SJR is a prestige metric based on the idea that not all citations are the same. ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC Under the (Learn More), The h-index is an author-level metric that attempts to measure both A platform by researchers, for researchers Copyright 2022 - www.researchbite.com - All Rights Reserved.
Translational Neurodegeneration Impact Factor: | Exaly The number of BMC and Springer yearly downloads of TN publications was around 26,000 in 2012. Chief Editors can at any stage of the peer-review step in to comment on the review process, change assigned editors, assign themselves as a reviewer and even as the handling editor for the manuscript, and therefore have full authority and all the mechanisms to act independently in their online editorial office to ensure quality. Translational Neuroscience. That is why Frontiers provides online free and open access to all of The work can be freely shared and adapted provided that Review Editors and reviewers are mandated to only accept to review a manuscript if they have no conflicts of interest (as stated here and in their review invitation and assignment emails). Associate Professor, University of Hertfordshire, Hatfield, UK. The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. In TN, we will strive to do our utmost best to facilitate research to achieve these goals in the next ten years. Translational Neurodegeneration is covered by a wide range of abstracting/indexing services including Scopus, Journal Citation Reports ( Clarivate ) and Research.com. It is computed in the year 2022. Each Frontiers article strives for the highest quality, thanks to superficial review, light review or no-review publishing models. Impact Factor 8.861 I. There are several factors that influence the acceptance rate of any academic journal. Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
Translational Neuroscience Impact Factor IF 2022|2021|2020 - BioxBio The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from
It considers the number of citations received by a journal and the importance of the journals from where these citations come. The complexity of the peer review process and timeline. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. Special thanks also go to Drs. The overall rank of Translational Neurodegeneration is 1426. Authors are therefore free to disseminate and re-publish their Search. (2 years)). obliterated, deleted or hidden, totally or partially. After a certain time frame and if no reviewers have in the meantime been assigned to the manuscript, the Frontiers platform and algorithmic safety-net steps in and invites the most appropriate Review Editors based on constantly updated and improved algorithms that match reviewer expertise with the submitted manuscript. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. Most recently at Kings College London, in collaboration with Professors Paul Francis and Clive Ballard, he investigated the anti-apoptotic and anti-aggregative role of various agents in the lactacystin model of Parkinsons disease. Associate Editors are mandated to only accept to edit a manuscript if they have no conflicts of interest (as stated here and in their review invitation and assignment emails).
Simi Valley Smog Check Coupons,
Tennessee River Cruise Overnight,
Toddler Girl Uniform Skort,
Articles T